Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Endo Int'l Plc (ENDPQ)

Endo Int'l Plc (ENDPQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 141
  • Shares Outstanding, K 235,220
  • Annual Sales, $ 2,012 M
  • Annual Income, $ -2,450 M
  • EBIT $ -1,232 M
  • EBITDA $ -925 M
  • 60-Month Beta 0.59
  • Price/Sales 0.00
  • Price/Cash Flow 0.00
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 3.00
  • Most Recent Earnings $0.64 on 03/06/24
  • Next Earnings Date 05/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0001 +500.00%
on 04/11/24
0.0040 -85.00%
on 04/16/24
+0.0002 (+50.00%)
since 04/01/24
3-Month
0.0001 +500.00%
on 04/11/24
0.0053 -88.68%
on 02/05/24
unch (unch)
since 02/01/24
52-Week
0.0001 +500.00%
on 04/11/24
0.0800 -99.25%
on 06/09/23
-0.0617 (-99.04%)
since 05/01/23

Most Recent Stories

More News
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada

/CNW/ -- Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride...

ENDPQ : 0.0006 (unch)
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®

/CNW/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800...

ENDPQ : 0.0006 (unch)
Endo Announces Confirmation of Plan of Reorganization

/CNW/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that the United States Bankruptcy Court for the Southern District of New...

ENDPQ : 0.0006 (unch)
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS

/CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2023. FOURTH-QUARTER FINANCIAL...

ENDPQ : 0.0006 (unch)
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER

/CNW/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that its subsidiary, Endo Health Solutions Inc. ("EHSI"), has agreed to...

ENDPQ : 0.0006 (unch)
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open

/CNW/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase Clostridium...

ENDPQ : 0.0006 (unch)
Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada

/CNW/ -- Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada....

ENDPQ : 0.0006 (unch)
Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting

/CNW/ -- Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren's contracture and XIAFLEX® (collagenase...

ENDPQ : 0.0006 (unch)
ENDO FILES PLAN OF REORGANIZATION TO IMPLEMENT PREVIOUSLY ANNOUNCED SALE TRANSACTION

/CNW/ -- Endo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced that it has taken an important step toward concluding its financial...

ENDPQ : 0.0006 (unch)
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients

/CNW/ -- Endo International plc (OTC: ENDPQ) announced today the launch of its new branded video series, PD Pool Hall, which aims to educate people about...

ENDPQ : 0.0006 (unch)

Business Summary

Endo International plc is a global specialty pharmaceutical company, which is focused on branded and generic pharmaceuticals. The four reportable business segments are: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. The Branded...

See More

Key Turning Points

3rd Resistance Point 0.0006
2nd Resistance Point 0.0006
1st Resistance Point 0.0006
Last Price 0.0006
1st Support Level 0.0006
2nd Support Level 0.0006
3rd Support Level 0.0006

See More

52-Week High 0.0800
Fibonacci 61.8% 0.0495
Fibonacci 50% 0.0400
Fibonacci 38.2% 0.0306
Last Price 0.0006
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar